Saturday, January 31, 2026

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

LG Display’s Bold Move: How OLED Technology is Revolutionizing Humanoid Robots in 2026

LG Display's CEO Jeong Cheol-dong discusses advancements in humanoid robots and OLED technology at CES 2026, emphasizing innovation and competition.

Bitcoin Price Dips Again: What’s Behind the Latest Drop?

Bitcoin (BTC) has continued its downward trend following news of significant U.S. government transfers and outflows from ETFs.

Tag: genetic testing

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.